• Home
  • Medicaid's Expenditures for Newwe Pharmacotherapies for Adults with Disabilities

Medicaid's Expenditures for Newwe Pharmacotherapies for Adults with Disabilities

Shireman, T., Hall, J.P., Rigler, S.K., & Moore, J.M. (2007). Medicaid’s expenditures for newer pharmacotherapies for adults with disabilities. Health Care Financing Review, 28(4), 31-42. 

Topic: Health/Employment for People with Disabilities 
Subcategory: Research
Summary: This study analyzed Kansas Medicaid data to describe trends in medication use patterns among disabled beneficiaries and found marked shifts toward newer medications and disproportionate contributions from several classes of newer, more expensive medications to overall prescription costs.

 

Go back to the Research main page.


Follow KUCRL 

 

Countdown to

48 nationally ranked graduate programs.
—U.S. News & World Report
Pharmacy school No. 2 nationally for NIH funding
Hall Center receives 3rd NEH challenge grant to support humanities research collaboration
Regional leader in technology commercialization
12 graduate programs rank in top 10 nationally among public universities.
—U.S. News & World Report
KU Today